Accessibility Menu
Kyowa Kirin logo

Kyowa Kirin(OTC) KYKOF

Market Cap$7.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+181%
5 Year-47%
1 Year-13%
1 Month+2%
$14.21
+0.00%
+0.00Today
Kyowa Kirin last closing stock price
MetricPriceDate
Last closeUSD 14.432026-08-10
Kyowa Kirin stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 14.432026-08-03
1 month+1.51%USD 14.212026-06-30
3 month+1.51%USD 14.212026-05-12
Year to date-6.38%USD 15.412025-12-31
1 year-13.4%USD 16.662025-07-31
3 year-15.04%USD 16.982023-08-10
5 year-46.86%USD 27.142021-07-15
Since inception+180.71%USD 5.142003-07-31

Kyowa Kirin Financials at a Glance

Market Cap

$7.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥529.93B

Net Income (TTM)

¥81.34B

EPS (TTM)

$1.01

P/E Ratio

14.32

Dividend

$0.42

Beta (Volatility)

0.05 (Low)

Price

$14.21

Volume

33

Open

$14.21

Previous Close

$14.21

Daily Range

$14.21 - $14.21

52-Week Range

$12.42 - $18.00

Estimated Earnings Date

Oct 29, 2026

KYKOF News

m&A

Why Orchard Therapeutics Stock Is Soaring Today

George Budwell, PhDOct 5, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kyowa Kirin

Kyowa Kirin Co., Ltd. is a global pharmaceutical company focused on developing, manufacturing, and commercializing innovative medicines. The company specializes in therapeutic areas such as oncology, nephrology, central nervous system disorders, and immunological conditions.

Products and Services
  • ABSTRAL for breakthrough cancer pain management
  • CONIEL, a calcium channel blocker for hypertension
  • Nouriast for Parkinson's disease treatment
Growth Outlook
  • Recent quarterly revenue reached JPY 144.1 billion, showing strong demand
  • TTM net income margin stands at 15.35%, indicating profitability
  • Strategic partnerships, like with Amgen, enhance product pipeline
Financial Highlights
  • TTM revenue of JPY 525.5 billion, reflecting consistent growth
  • Current ratio of 2.84, indicating strong liquidity
  • Dividend yield of 2.73%, appealing for income-focused investors
Kyowa Kirin Co., Ltd. has established itself as a key player in the pharmaceutical industry, with a diverse portfolio of products addressing critical health issues. The company's focus on research and development, alongside strategic collaborations, positions it well for future growth. Recent financial performance highlights a robust revenue stream and solid profitability, making it an attractive option for potential investors. The strong liquidity ratios further enhance its financial stability, while the dividend yield offers an additional incentive for income-seeking investors. Overall, Kyowa Kirin's commitment to innovation and strategic growth initiatives underscores its potential in the competitive pharmaceutical landscape.
AI Generated • Aug 4, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,161

CEO

Abdul Mullick, PhD

Website

www.kyowa-kirin.co.jp

Headquarters

Tokyo, TY 100-0004, JP

KYKOF Financials

Key Financial Metrics (TTM)

Gross Margin

73.91%

Operating Margin

24.38%

Net Income Margin

15.35%

Return on Equity

9.17%

Return on Capital

11.12%

Return on Assets

7.19%

Earnings Yield

6.98%

Dividend Yield

2.91%

Payout Ratio

39.90%

Stock Overview

Market Cap

$7.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

523.59M

Volume

33

Avg. Volume

128.968

Financials (TTM)

Gross Profit

¥392.76B

Operating Income

¥119.54B

EBITDA

¥158.41B

Operating Cash Flow

¥142.14B

Capital Expenditure

-¥38.80B

Free Cash Flow

¥103.34B

Cash & ST Invst.

¥263.17B

Total Debt

¥22.04B

Kyowa Kirin Performance Analysis

Kyowa Kirin annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31JPY 3,028,800,292-5.5%
20232023-12-31JPY 3,145,038,2043.8%
20242024-12-31JPY 3,271,119,9434.0%
20252025-12-31JPY 3,321,040,1671.5%
Kyowa Kirin sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-4.3%
Q42025-12-3121.3%
Q12026-03-31-18.4%
Q22026-06-3020.9%
Kyowa Kirin annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31JPY 0.76-14.5%
20232023-12-31JPY 1.0741.7%
20242024-12-31JPY 0.75-30.5%
20252025-12-31JPY 0.8614.7%
Kyowa Kirin sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3062.6%
Q42025-12-31107.5%
Q12026-03-31-65.8%
Q22026-06-3058.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

¥144.11B

+14.4%

Gross Profit

¥105.27B

+18.7%

Gross Margin

73.05%

N/A

Market Cap

$7.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.46M

N/A

Employees

5,161

N/A

Net Income

¥18.45B

+81.7%

EBITDA

¥50.54B

+183.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

¥263.17B

+11.4%

Total Debt

¥22.04B

+13713.1%

Accounts Receivable

¥152.19B

-4.1%

Inventory

¥64.22B

-11.9%

Long Term Debt

¥22.04B

N/A

Short Term Debt

¥0.00

N/A

Return on Assets

7.19%

N/A

Return on Invested Capital

13.62%

N/A

Free Cash Flow

¥18.60B

-21.6%

Operating Cash Flow

¥24.82B

-23.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SSMXYSysmex Corporation
$12.02+1.52%
GIFLFGrifols, S.A.
$11.76+0.00%
OPHLYOno Pharmaceutical Co., Ltd.
$5.03+0.40%
SKHCFSonic Healthcare Limited
$14.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.27+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.65+0.00%
ONDSOndas
$9.50+0.07%
INTCIntel
$103.33-0.01%

Questions About KYKOF

What is the current price of Kyowa Kirin?

Kyowa Kirin is trading at $14.21 per share.

What is the 52-week range for Kyowa Kirin?

Over the past 52 weeks, Kyowa Kirin has traded between $12.42 and $18.00.

How much debt does Kyowa Kirin have?

As of the most recent reporting period, Kyowa Kirin reported total debt of ¥136.61M.

How much cash does Kyowa Kirin have on hand?

Kyowa Kirin reported ¥1.63B in cash and cash equivalents in its most recent financial results.

What is Kyowa Kirin’s dividend yield?

Kyowa Kirin currently has a dividend yield of 2.91%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services